Cargando…
The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
SIMPLE SUMMARY: Patients diagnosed with pancreatic cancer have very few treatment options. In order to identify new treatment opportunities, and develop new drugs for clinical use, appropriate model systems that take into account the complexities of a tumor are required. In this review, we summarize...
Autores principales: | Low, Ronnie Ren Jie, Lim, Wei Wen, Nguyen, Paul M., Lee, Belinda, Christie, Michael, Burgess, Antony W., Gibbs, Peter, Grimmond, Sean M., Hollande, Frédéric, Putoczki, Tracy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508245/ https://www.ncbi.nlm.nih.gov/pubmed/34638463 http://dx.doi.org/10.3390/cancers13194979 |
Ejemplares similares
-
S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer
por: Low, Ronnie Ren Jie, et al.
Publicado: (2023) -
Correction to: S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer
por: Low, Ronnie Ren Jie, et al.
Publicado: (2023) -
Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy
por: Gong, Miaomiao, et al.
Publicado: (2023) -
Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma
por: Feigin, Michael E., et al.
Publicado: (2017) -
A microenvironment-inspired synthetic 3D model for pancreatic ductal adenocarcinoma organoids
por: Below, Christopher R., et al.
Publicado: (2022)